SEC Form 4 · accession 0001078782-15-001351
VOLITIONRX LTD · VNRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David Matthew Kratochvil
Officer — Chief Financial Officer
Period of report
Aug 17, 2015
Accepted (ET)
Aug 17, 2015 · 5:28 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000093314
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionF1 | $3.75 | Aug 17, 2015 | A | 75,000 | A | Aug 17, 2015 | Aug 17, 2020 | Common Stock | 75,000 | 75,000 | D |
Explanation of responses
- F1A total of 75,000 Options were granted on August 17, 2015 under the Company's 2011 Equity Incentive Plan. The Options vest in full on the date of grant.